Search
for

    GlossaryInterleukin-22 (IL-22)

    protein that regulates inflammation and tissue repair in the body

    Interleukin-22 (IL-22) is a type of protein called a cytokine that plays a crucial role in the immune system. It helps regulate inflammation and the body's response to infections, particularly in tissues like the skin and gut. IL-22 is produced by immune cells and can influence the behavior of other cells, promoting tissue repair and defense against pathogens.

    Related Terms

    Learn

    3 / 3 results

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

      learn Redensyl

      commercial product with a blend of mostly natural ingredients for hair regrowth

    Research

    5 / 1000+ results

    Community Join

    5 / 127 results

      community 1 year on Fin and Min. Diffuse thinner.

      in Is this regrowth?  18 upvotes 1 year ago
      The conversation is about a user experiencing hair loss who has been using finasteride for a year and minoxidil once a day for five months, but still experiences shedding and thin hair. The user is considering switching to dutasteride next year and shares their progress with others using similar treatments.

      community Breaking hair loss news! GT20029 is a resounding success!

      in Product  132 upvotes 1 year ago
      GT20029, a new hair loss treatment, shows promising results but only a slight improvement over placebo. People are cautiously optimistic, discussing its potential and combining it with existing treatments like Minoxidil and Finasteride.

      community I will have it cured by morning

      in Research/Science  370 upvotes 3 years ago
      Researching the cause of hair loss and treating it by preventing DHT in the scalp with medication such as finasteride or dutasteride, estrogen, minoxidil, dermarolling, and possible topical antiandrogens.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.